17 June 2025
: Case report
[In Press] Sacral Neuromodulation for Post-Hysterectomy Hydroureteronephrosis in a Patient with Cervical Cancer: A Case Report
Unusual clinical course, Unusual or unexpected effect of treatment
Fuhao Ji1ABEF, Lei Xu1BDF, Jiayi Li1ABEFDOI: 10.12659/AJCR.948967
Am J Case Rep In Press; DOI: 10.12659/AJCR.948967
Available online: 2025-06-17, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Uterine cervical cancer in its early stage is managed with a standard treatment protocol of radical hysterectomy with bilateral pelvic lymphadenectomy. Common complications after the surgery include hydronephrosis, partially leading to renal failure. Currently, there are few reports on upper urinary tract function impairment caused by delayed lower urinary tract dysfunction after radical hysterectomy. Here, we present a case in which sacral neuromodulation (SNM) was successfully used to treat severe hydroureteronephrosis after radical hysterectomy for uterine cervical cancer.
CASE REPORT
A 44-year-old woman was diagnosed with bilateral hydroureteronephrosis and renal insufficiency (serum creatinine at 287 µmol/L) more than 1 year after undergoing radical hysterectomy for uterine cervical cancer. After utilizing an indwelling catheter for 3 months, her renal function showed a progressive improvement and stabilized at around 126 µmol/L. Videourodynamic study (VUDS) indicated decreased bladder compliance, bilateral ureteral reflux, with the reflux graded as IV-V. After confirmation that the upper urinary tract damage was caused by the elevated bladder pressure and not by invasion of the bladder by the primary tumor, SNM was performed to restore lower urinary tract function and to maintain low-pressure urine storage and micturition. Currently, 4 years after the surgery, the creatinine level has progressively declined to 75 µmol/L. Ultrasonography revealed no signs of hydronephrosis. Routine urine tests and post-void residual urine volumes are normal.
CONCLUSIONS
In select patients, sacral neuromodulation can protect the upper urinary tract, probably by improving lower urinary tract function.
Keywords: Hydronephrosis; Hysterectomy; Neurofeedback; Uterine Cervical Neoplasms; Lower Urinary Tract Symptoms
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948283
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947725
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947694
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947174
Most Viewed Current Articles
21 Jun 2024 : Case report
102,230
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,598
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
38,437
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
26,104
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200